This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/russia/524250-putnik-vaccine-eu-political-pressure/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 1 | Version 2 |
|---|---|
| Russian Sputnik V Covid-19 vaccine hasn’t been approved by EU due to political pressure from top officials – Moscow’s spy chief | Russian Sputnik V Covid-19 vaccine hasn’t been approved by EU due to political pressure from top officials – Moscow’s spy chief |
| (about 2 months later) | |
| Russia’s Sputnik V Covid-19 vaccine has yet to be registered in the European Union due to political pressure from the bloc’s leaders. That’s according to Sergey Naryshkin, head of the country’s Foreign Intelligence Service (SVR). | Russia’s Sputnik V Covid-19 vaccine has yet to be registered in the European Union due to political pressure from the bloc’s leaders. That’s according to Sergey Naryshkin, head of the country’s Foreign Intelligence Service (SVR). |
| Speaking on national television, Russia’s top spy said that the European Medicines Agency (EMA) is “dragging its feet” because of influence from the top of the EU, and not due to any genuine scientific concern. | Speaking on national television, Russia’s top spy said that the European Medicines Agency (EMA) is “dragging its feet” because of influence from the top of the EU, and not due to any genuine scientific concern. |
| “I don’t want to blame the experts and specialists of the European Medicines Agency,” Naryshkin said. “But we reliably know that this procrastination is related to signals that come from on high of the European Union.” | “I don’t want to blame the experts and specialists of the European Medicines Agency,” Naryshkin said. “But we reliably know that this procrastination is related to signals that come from on high of the European Union.” |
| The EMA has been studying Sputnik V for some time, and started officially reviewing the vaccine in March. However, a decision has been slow to come from the regulator, despite published research showing the vaccine to be as good as or better than registered jabs. The Russian Direct Investment Fund, which financed the shot, claims it has shown 97.6% effectiveness in what it termed a “real-world study.” An appraisal published in February in the British medical journal The Lancet showed 91.6% efficacy. | The EMA has been studying Sputnik V for some time, and started officially reviewing the vaccine in March. However, a decision has been slow to come from the regulator, despite published research showing the vaccine to be as good as or better than registered jabs. The Russian Direct Investment Fund, which financed the shot, claims it has shown 97.6% effectiveness in what it termed a “real-world study.” An appraisal published in February in the British medical journal The Lancet showed 91.6% efficacy. |
| The latest accusations come a day after Naryshkin claimed that the EU is preparing a smear campaign against Russia, saying that Brussels wants to accuse Moscow of inciting an anti-vaccination movement abroad. | The latest accusations come a day after Naryshkin claimed that the EU is preparing a smear campaign against Russia, saying that Brussels wants to accuse Moscow of inciting an anti-vaccination movement abroad. |
| In March, Russian President Vladimir Putin claimed that foreign interest in Sputnik V is growing, despite what he called “deliberate discrediting” and “outright fabrications.” | In March, Russian President Vladimir Putin claimed that foreign interest in Sputnik V is growing, despite what he called “deliberate discrediting” and “outright fabrications.” |
| If you like this story, share it with a friend! | If you like this story, share it with a friend! |